Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: Preparation, characterization, in-vitro release, and cytotoxicity analysis

Anti-Cancer Drugs

Volumn 22, Issue 8, 2011, Pages 774-782

  Alvi, Iqrar Ali ^a   Madan, Jitender ^a   Kaushik, Dinesh ^a   Sardana, Satish ^a   Pandey, Ravi Shankar ^b   Ali, Asgar ^c  

^a Hindu College   (India)

^b GURU GHASIDAS UNIVERSITY   (India)

^c HAMDARD UNIVERSITY   (India)

Author keywords

5 fluorouracil; liposomes; niosomes; topical; transfersomes

Indexed keywords

DRUG CARRIER; FLUOROURACIL; LIPOSOME; NIOSOME; SOLVENT; TRANSFERSOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER CELL; CANCER CELL CULTURE; CELL MEMBRANE PERMEABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ANALYSIS; DRUG FORMULATION; DRUG RELEASE; EVAPORATION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SKIN CANCER; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY; ZETA POTENTIAL;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; FLUOROURACIL; HUMANS; LIPOSOMES; MALE; PARTICLE SIZE; PERMEABILITY; RATS; SKIN ABSORPTION; SKIN NEOPLASMS; VISCOSITY;

EID: 80051507034     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0b013e328346c7d6     Document Type: Article

References (23)

1. Van Ruth S, Jansman FG, Sanders CJ. Total body topical 5-fluorouracil for extensive non-melanoma skin cancer. Pharm World Sci 2006; 28:159-162. (Pubitemid 44584049)
2. Gross K, Kircik L, Kricorian G. 5% 5-fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 2007; 33:433-440.
3. Morse LG, Kendrick C, Hooper D,Ward H, Parry E. Treatment of squamous cell carcinoma with intralesional 5-fluorouracil. Dermatol Surg 2003; 29:1150-1153. (Pubitemid 37370451)
4. Nguyen TH, Ho DQ. Nonmelanoma skin cancer. Curr Treat Options Oncol 2002; 3:193-203.
5. Gupta RR, Jain SK, Varshney M. AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil. Colloids Surf B: Biointerfaces 2005; 41:25-32. (Pubitemid 40215481)
6. Singh BN, Singh RB, Singh J. Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum. Int J Pharm 2005; 298:98-107. (Pubitemid 40828331)
7. Dodov MG, Kumbaradz EF, Goracinova K, Calis S, Simonoska M, Hincal A. 5-Fluorouracil in topical liposomal gels for anticancer treatment, formulation and evaluation. Acta Pharma 2003; 53:241-250. (Pubitemid 38083939)
8. Paolino D, Cosco D, Muzzalupo R, Trapasso E, Picci N, Fresta M. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm 2008; 353:233-242.
9. Shivanand P, Manish G, Virat D, Jarina F. Transferosomes: a novel approach for transdermal drug delivery. Der Pharmacia Lettre 2009; 1:143-150.
10. Fang JY, Hong CT, ChiuWT,Wang YY. Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 2001; 219:61-72.
11. Hao Y, Zhao F, Li N, Yang Y, Li K. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 2002; 244:73-80. (Pubitemid 35245447)
12. Madan J, Dhiman N, Parmar VK, Sardana S, Bharatam PV, Aneja R, et al. Inclusion complexes of noscapine in b-cyclodextrin offer better solubility and improved pharmacokinetics. Cancer Chemother Pharmacol 2010; 65:537-548.
13. Madan J, Dhiman N, Sardana S, Aneja R, Chandra R, Katyal A. Long circulating poly(ethylene glycol)-grafted gelatin nanoparticles customized for intracellular delivery of noscapine: preparation, in-vitro characterization, structure elucidation, pharmacokinetic and cytotoxicity analysis. Anticancer Drugs 2011 (in press).
14. Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA, et al. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 1993; 14:833-839. (Pubitemid 23169134)
15. Jain S, Jain P, Maheshwarim RB, Jain NK. Transfersomes, a novel carrier for enhanced transdermal delivery: development, characterization and performance evaluation. Drug Dev Ind Pharm 2003; 29:1013-1026. (Pubitemid 37346103)
16. Madan J, Kaushik D, Sardana S, Mishra DN, Singh SK, Singh BK. Effect of amoxicillin and chloroquine on humoral immune response elicited by bovine serum albumin encapsulated in liposomes. Acta Pharm 2008; 58:479-487.
17. Madan J, Kaushik D, Sardana S, Mishra DN. Effect of ciprofloxacin and chloramphenicol on humoral immune response elicited by bovine serum albumin encapsulated in niosomes. Acta Pharm Sinica 2007; 42:905-910.
18. Tian Z, Jun GJ, Xie SQ, Zhao J, Yuan W, Wang CJ. Analytical estimation of 5-Fluorouracil. Molecule 2007; 12:2450-2457.
19. Gupta PN, Mishra V, Rawat A, Dubey P, Mohar S, Jain S, et al. Non-invasive vaccine delivery in transfersomes, liposomes and niosomes: a comparative study. Int J Pharm 2005; 293:73-82. (Pubitemid 40381082)
20. Aggarwal R, Katare OP, Vyas SP. Preparation and in-vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 2001; 228:43-52. (Pubitemid 32905364)
21. Szoka FC, Papahadjopoulas D. Procedure for the preparation of liposomes with large aqueous space and high captures by reverse phase evaporation method. Proc Natl Acad Sci USA 1978; 75:4194-4198.
22. Aggarwal R, Katare OP. Miconazole nitrate loaded topical liposomes. Pharm Tech 2002; 26:48-60.
23. Mishra B. Topical drug delivery. Ind J Exp Biol 1990; 28:1001-1017.